Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

Valo Health is eligible for a further $1.9 billion in potential milestone payments for up to nine new drug programs "Novo Nordisk, Valo Health Expand Drug Discovery and Development Pact -- Update," at ...

The Dow, S&P 500, and Nasdaq are struggling to find a direction Wednesday as the stock market braces for minutes from the Fed's monetary policy meeting.

Overview: Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥4.37 billion. Operations: ...

The largest project underway is Novo Nordisk’s $4.1 billion expansion ... Fujifilm works with pharmaceutical and biotechnology companies to produce biologics, vaccines and other advanced therapies.

As the demand for these drugs soars, pharmaceutical giants like Novo Nordisk and Eli Lilly have seen massive profits, with Novo’s GLP-1 sales raking in over $6 billion in 2023 alone. Despite the ...

What’s going on here? Novo Nordisk shares suffered their sharpest drop ever after the pharmaceutical giant’s experimental obesity drug failed to live up to expectations. Weight-loss drugs have been ...